Included in the formulation
АТХ:J.07.A.X Other vaccines for the prevention of bacterial infections
Pharmacodynamics:It causes the formation of antibodies against staphylococci, Proteus and Pseudomonas aeruginosa, accelerates the phagocytic function of neutrophils.
Pharmacokinetics:Not described.
Indications:It is used to prevent purulent-septic complications.
I.A30-A49.A49 Bacterial infection of unspecified site
I.A30-A49.A49.0 Staphylococcal infection, unspecified
I.B99 Other infectious diseases
XXI.Z20-Z29.Z29.1 Prophylactic immunotherapy
Contraindications:Age to 18 years, pregnancy and lactation, individual intolerance.
Carefully:History of hypersensitivity to the introduction of vaccines.
Pregnancy and lactation:Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.
Dosing and Administration:Subcutaneously once in an amount of 0.5 ml with isolated injuries and closed fractures.
In case of extensive injuries and before routine surgical interventions - three times: 0.5 ml - as a primary dose, then twice in 1 ml with an interval of 14-20 days.
The highest daily dose: 1 ml.
The highest single dose: 1 ml.
Side effects:Systemic reactions: hyperthermia, weakness.
Local reactions: pain and hyperemia at the injection site.
Allergic reactions.
Overdose:Cases of overdose are not described.
Treatment is symptomatic.
Interaction:It is not recommended simultaneous administration of the drug with antistaphylococcal immunoglobulin and antistaphylococcal plasma due to the phenomenon of mutual neutralization.
Special instructions:Conducting a specific vaccination is not the reason for the cancellation of treatment with other drugs: antibacterial, anti-inflammatory and other.